https://stock.noler.com/us/stock/biora-therapeutics-inc https://stock.noler.com/us/stock/biora-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/biora-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/biora-therapeutics-inc/accrued-insurance-current https://stock.noler.com/us/stock/biora-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/biora-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/biora-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/biora-therapeutics-inc/advertising-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/amortization https://stock.noler.com/us/stock/biora-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/biora-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/biora-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/biora-therapeutics-inc/assets-net https://stock.noler.com/us/stock/biora-therapeutics-inc/assets-of-disposal-group-including-discontinued-operation https://stock.noler.com/us/stock/biora-therapeutics-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/biora-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-lease-obligations https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leased-assets-gross https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-balance-sheet-assets-by-major-class-net https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-future-minimum-payments-due-current https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-future-minimum-payments-due-in-two-years https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-future-minimum-payments-due-thereafter https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-future-minimum-payments-interest-included-in-payments https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biora-therapeutics-inc/capital-leases-lessee-balance-sheet-assets-by-major-class-accumulated-deprecation https://stock.noler.com/us/stock/biora-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/biora-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/biora-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/biora-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/biora-therapeutics-inc/cash-provided-by-used-in-financing-activities-discontinued-operations https://stock.noler.com/us/stock/biora-therapeutics-inc/cash-provided-by-used-in-investing-activities-discontinued-operations https://stock.noler.com/us/stock/biora-therapeutics-inc/cash-provided-by-used-in-operating-activities-discontinued-operations https://stock.noler.com/us/stock/biora-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/biora-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/biora-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/biora-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/biora-therapeutics-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/biora-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/biora-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/biora-therapeutics-inc/contractual-obligation https://stock.noler.com/us/stock/biora-therapeutics-inc/contractual-obligation-due-in-fifth-year https://stock.noler.com/us/stock/biora-therapeutics-inc/contractual-obligation-due-in-fourth-year https://stock.noler.com/us/stock/biora-therapeutics-inc/contractual-obligation-due-in-next-twelve-months https://stock.noler.com/us/stock/biora-therapeutics-inc/contractual-obligation-due-in-second-year https://stock.noler.com/us/stock/biora-therapeutics-inc/contractual-obligation-due-in-third-year https://stock.noler.com/us/stock/biora-therapeutics-inc/convertible-debt-current https://stock.noler.com/us/stock/biora-therapeutics-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/biora-therapeutics-inc/convertible-notes-payable https://stock.noler.com/us/stock/biora-therapeutics-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/biora-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/biora-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/biora-therapeutics-inc/current-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/biora-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/biora-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/biora-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/biora-therapeutics-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/biora-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/biora-therapeutics-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/biora-therapeutics-inc/debt-unamortized-discount https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-offering-costs https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-sales-inducement-cost-impairment-loss https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-reserves https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-goodwill https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/biora-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/biora-therapeutics-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/biora-therapeutics-inc/depreciation https://stock.noler.com/us/stock/biora-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/biora-therapeutics-inc/derivative-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/derivative-liabilities-current https://stock.noler.com/us/stock/biora-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/biora-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/biora-therapeutics-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/biora-therapeutics-inc/discontinued-operation-income-loss-from-discontinued-operation-before-income-tax https://stock.noler.com/us/stock/biora-therapeutics-inc/disposal-group-including-discontinued-operation-assets-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/disposal-group-including-discontinued-operation-costs-of-goods-sold https://stock.noler.com/us/stock/biora-therapeutics-inc/disposal-group-including-discontinued-operation-general-and-administrative-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/disposal-group-including-discontinued-operation-gross-profit-loss https://stock.noler.com/us/stock/biora-therapeutics-inc/disposal-group-including-discontinued-operation-operating-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/disposal-group-including-discontinued-operation-revenue https://stock.noler.com/us/stock/biora-therapeutics-inc/dividends-declared https://stock.noler.com/us/stock/biora-therapeutics-inc/dividends-paid https://stock.noler.com/us/stock/biora-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/biora-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/biora-therapeutics-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/biora-therapeutics-inc/eps https://stock.noler.com/us/stock/biora-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/biora-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/biora-therapeutics-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/biora-therapeutics-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/biora-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/biora-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/biora-therapeutics-inc/finance-lease-liability-current https://stock.noler.com/us/stock/biora-therapeutics-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/biora-therapeutics-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/biora-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/biora-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/biora-therapeutics-inc/gain-loss-on-investments https://stock.noler.com/us/stock/biora-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/biora-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/biora-therapeutics-inc/gains-losses-on-restructuring-of-debt https://stock.noler.com/us/stock/biora-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/goodwill https://stock.noler.com/us/stock/biora-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/biora-therapeutics-inc/goodwill-written-off-related-to-sale-of-business-unit https://stock.noler.com/us/stock/biora-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/biora-therapeutics-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/biora-therapeutics-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-attributable-to-reporting-entity https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-and-diluted-share https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-basic-share https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax-per-diluted-share https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-per-basic-share https://stock.noler.com/us/stock/biora-therapeutics-inc/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/biora-therapeutics-inc/income-tax https://stock.noler.com/us/stock/biora-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/biora-therapeutics-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/biora-therapeutics-inc/income-tax-receivable https://stock.noler.com/us/stock/biora-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/biora-therapeutics-inc/income-taxes-receivable https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/induced-conversion-of-convertible-debt-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/biora-therapeutics-inc/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/biora-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/biora-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/biora-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/biora-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/biora-therapeutics-inc/intangible-assets-current https://stock.noler.com/us/stock/biora-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/biora-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/biora-therapeutics-inc/interest-receivable https://stock.noler.com/us/stock/biora-therapeutics-inc/inventory https://stock.noler.com/us/stock/biora-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/biora-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/biora-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biora-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/biora-therapeutics-inc/liabilities-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/biora-therapeutics-inc/liabilities-of-disposal-group-including-discontinued-operation-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/litigation-settlement-amount-awarded-to-other-party https://stock.noler.com/us/stock/biora-therapeutics-inc/litigation-settlement-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/loss-on-contract-termination https://stock.noler.com/us/stock/biora-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/biora-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/biora-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/biora-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/biora-therapeutics-inc/net-income https://stock.noler.com/us/stock/biora-therapeutics-inc/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/biora-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/biora-therapeutics-inc/notes-payable-fair-value-disclosure https://stock.noler.com/us/stock/biora-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/biora-therapeutics-inc/oci-tax https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-income https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/biora-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/biora-therapeutics-inc/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/other-income https://stock.noler.com/us/stock/biora-therapeutics-inc/other-long-term-debt-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/other-sundry-liabilities-noncurrent https://stock.noler.com/us/stock/biora-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/biora-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/biora-therapeutics-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/biora-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/biora-therapeutics-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/biora-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/biora-therapeutics-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/biora-therapeutics-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/biora-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/biora-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/biora-therapeutics-inc/prepaid-expense-current https://stock.noler.com/us/stock/biora-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-sale-of-equity-method-investments https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-sale-of-equity-securities-fv-ni https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-sale-of-other-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-sale-of-property-held-for-sale https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/biora-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/biora-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/biora-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/biora-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/biora-therapeutics-inc/public-float https://stock.noler.com/us/stock/biora-therapeutics-inc/repayments-of-secured-debt https://stock.noler.com/us/stock/biora-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/biora-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/biora-therapeutics-inc/restricted-cash-and-investments https://stock.noler.com/us/stock/biora-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/biora-therapeutics-inc/revenue https://stock.noler.com/us/stock/biora-therapeutics-inc/revenues https://stock.noler.com/us/stock/biora-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/biora-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/biora-therapeutics-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/sga-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/biora-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/biora-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/biora-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/biora-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-reconciliation-tax-settlements https://stock.noler.com/us/stock/biora-therapeutics-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/biora-therapeutics-inc/total-assets https://stock.noler.com/us/stock/biora-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/biora-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/biora-therapeutics-inc/treasury-stock-common-shares https://stock.noler.com/us/stock/biora-therapeutics-inc/treasury-stock-common-value https://stock.noler.com/us/stock/biora-therapeutics-inc/utb-change https://stock.noler.com/us/stock/biora-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/biora-therapeutics-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/biora-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted